SCHEMBL24254545

SCHEMBL24254545

Cc1ccc(SN(C)C)cc1NC(=O)Cc1ccc(O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SELL P14151 1/20 0.45
SELP P16109 1/20 0.45
HPGD P15428 1/20 0.45
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
POLB P06746 2/20 0.44
HTT P42858 2/20 0.44
BCHE P06276 2/20 0.43
ACHE P22303 2/20 0.43
RAF1 P04049 1/20 0.43
NLRP3 Q96P20 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 2/20 0.40
KCNJ6 P48051 1/20 0.39
KCNJ5 P48544 1/20 0.39
KCNJ3 P48549 1/20 0.39
MAPT P10636 2/20 0.38
PKM P14618 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24254523 0.89 HPGD (0.59) SELLSELPHPGDKMT2AMEN1
SCHEMBL24254578 0.85 L3MBTL1 (0.57) KMT2AMEN1POLBHTTL3MBTL1
SCHEMBL24254575 0.84 MAPT (0.53) KMT2AMEN1POLBHTTL3MBTL1
SCHEMBL24254539 0.78 MAPT (0.53) KMT2AMEN1HTTLMNAGAA
SCHEMBL24254504 0.77 ALDH1A1 (0.63) KMT2APOLBL3MBTL1LMNAGAA
SCHEMBL24254498 0.77 ALDH1A1 (0.63) SELLSELPKMT2AMEN1POLB
SCHEMBL24254579 0.72 MEN1 (0.57) KMT2AMEN1POLBHTTL3MBTL1
SCHEMBL13388743 0.72 L3MBTL1 (0.54) HPGDKMT2AMEN1POLBHTT
SCHEMBL24254515 0.71 MAPT (0.48) KMT2AMEN1POLBHTTL3MBTL1
SCHEMBL14227343 0.69 ALDH1A1 (0.57) SELLSELPPOLBLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed